Enhanced expression of secretable influenza virus neuraminidase in suspension mammalian cells by influenza virus nonstructural protein 1

Journal of Virological Methods

Volumn 178, Issue 1-2, 2011, Pages 44-51

  Nivitchanyong, Tarangsri ^a   Yongkiettrakul, Suganya ^a   Kramyu, Jarin ^a   Pannengpetch, Supitcha ^a   Wanasen, Nanchaya ^a  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Influenza virus; Mammalian cell culture; Neuraminidase; Nonstructural protein 1; Transient gene expression

Indexed keywords

MYC PROTEIN; NONSTRUCTURAL PROTEIN 1; VIRUS SIALIDASE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; MICHAELIS CONSTANT; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; STEADY STATE; SUPERNATANT; VIRUS STRAIN;

BIOTECHNOLOGY; CELL CULTURE TECHNIQUES; CELL LINE; CLONING, MOLECULAR; FIBROBLASTS; GENE EXPRESSION; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; NEURAMINIDASE; RECOMBINANT PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 80955144158     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.08.010     Document Type: Article

References (41)

1. Backliwal G., Hildinger M., Chenuet S., Dejesus M., Wurm F.M. Coexpression of acidic fibroblast growth factor enhances specific productivity and antibody titers in transiently transfected HEK293 cells. N. Biotechnol. 2008, 25:162-166.
2. Boosani C.S., Varma A.K., Sudhakar A. Validation of different systems for tumstatin expression and its in-vitro and in-vivo activities. J. Cancer Sci. Ther. 2009, 8-18.
3. Bosch B.J., Bodewes R., de Vries R.P., Kreijtz J.H., Bartelink W., van Amerongen G., Rimmelzwaan G.F., de Haan C.A., Osterhaus A.D., Rottier P.J. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J. Virol. 2010, 84:10366-10374.
4. Burgui I., Aragon T., Ortin J., Nieto A. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J. Gen. Virol. 2003, 84:3263-3274.
5. Collins P.J., Haire L.F., Lin Y.P., Liu J., Russell R.J., Walker P.A., Skehel J.J., Martin S.R., Hay A.J., Gamblin S.J. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008, 453:1258-1261.
6. Compans R.W., Dimmock N.J., Meier-Ewert H. Effect of antibody to neuraminidase on the maturation and hemagglutinating activity of an influenza A2 virus. J. Virol. 1969, 4(4):528-534.
7. Dalakouras T., Smith B.J., Platis D., Cox M.M., Labrou N.E. Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase. J. Chromatogr. A 2006, 1136:48-56.
8. Dowdle W.R., Downie J.C., Laver W.G. Inhibition of virus release by antibodies to surface antigens of influenza viruses. J. Virol. 1974, 13(2):269-275.
9. de Jong M.D., Tran T.T., Truong H.K., Vo M.H., Smith G.J., Nguyen V.C., Bach V.C., Phan T.Q., Do Q.H., Guan Y., Peiris J.S., Tran T.H., Farrar J. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N. Engl. J. Med. 2005, 353:2667-2672.
10. de la Luna S., Fortes P., Beloso A., Ortin J. Influenza virus NS1 protein enhances the rate of translation initiation of viral mRNAs. J. Virol. 1995, 69:2427-2433.
11. Durocher Y., Perret S., Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002, 30:E9.
12. Geisse S. Reflections on more than 10 years of TGE approaches. Protein Expr. Purif. 2009, 64:99-107.
13. Girard P., Derouazi M., Baumgertner G., Bourgeois M., Jordan M., Jacko B., Wurm F.M. 100-Liter transient transfection. Cytotechnology 2002, 38:15-21.
14. Hale B.G., Steel J., Medina R.A., Manicassamy B., Ye J., Hickman D., Hai R., Schomolke M., Lowen A.C., Perez D.R., Garcia-Sastre A. Inefficient control of host gene expression by the 2009 pandamic H1N1 influenza A virus NS1 protein. J. Virol. 2010, 84:6909-6922.
15. Hoffmann E., Krauss S., Perez D., Webby R., Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 2002, 20:3165-3170.
16. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6108-6113.
17. Hogue B.G., Nayak D.P. Deletion mutation in the signal anchor domain activates cleavage of the influenza virus neuraminidase, a type II transmembrane protein. J. Gen. Virol. 1994, 75:1015-1022.
18. Imataka H., Gradi A., Sonenberg N. A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation. EMBO J. 1998, 17:7480-7489.
19. Kennard M.L., Goosney D.L., Monteith D., Zhang L., Moffat M., Fischer D., Mott J. The generation of stable, high MAb expressing CHO cell lines based on the artificial chromosome expression (ACE) technology. Biotechnol. Bioeng. 2009, 104:540-553.
20. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., Stevens R.C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 1997, 119:681-690.
21. Kiso M., Shinya K., Shimojima M., Takano R., Takahashi K., Katsura H., Kakugawa S., Le M.T., Yamashita M., Furuta Y., Ozawa M., Kawaoka Y. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses. PLoS Pathog. 2010, 6.
22. Le Q.M., Wertheim H.F., Tran N.D., van Doorn H.R., Nguyen T.H., Horby P. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N. Engl. J. Med. 2010, 362:86-87.
23. Leung T.W., Tai A.L., Cheng P.K., Kong M.S., Lim W. Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. J. Clin. Virol. 2009, 46:298-299.
24. Majors B.S., Betenbaugh M.J., Pederson N.E., Chiang G.G. Enhancement of transient gene expression and culture viability using Chinese hamster ovary cells overexpressing Bcl-x(L). Biotechnol. Bioeng. 2008, 101:567-578.
25. Marion R.M., Aragon T., Beloso A., Nieto A., Ortin J. The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res. 1997, 25:4271-4277.
26. Martinet W., Saelens X., Deroo T., Neirynck S., Contreras R., Min Jou W., Fiers W. Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur. J. Biochem. 1997, 247:332-338.
27. McKimm-Breschkin J.L., Caldwell J.B., Guthrie R.E., Kortt A.A. A new method for the purification of the influenza A virus neuraminidase. J. Virol. Methods 1991, 32:121-124.
28. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94:287-296.
29. Rameix-Welti M.A., Agou F., Buchy P., Mardy S., Aubin J.T., Véron M., van derWerf S., Naffakh N. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob. Agents Chemother. 2006, 50:3809-3815.
30. Salvatore M., Basler C.F., Parisien J.P., Horvath C.M., Bourmakina S., Zheng H., Muster T., Palese P., Garcia-Sastre A. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 2002, 76:1206-1212.
31. Schmidt P.M., Attwood R.M., Mohr P.G., Barrett S.A., McKimm-Breschkim J.L. A generic system for the expression and purification of soluble and stable influenza neuraminidase. PLoS One 2011, 6(2):e16284.
32. Segal I.H. Behavior and analysis of steady-state and rapid equilibrium enzyme system. Enzyme Kinetics 1975, 100-160. Wiley-Interscience, New York. I.H. Segal (Ed.).
33. Shaw M.L., Stone K.L., Colangelo C.M., Gulcicek E.E., Palese P. Cellular proteins in influenza virus particles. PLoS Pathog. 2008, 4:e1000085.
34. Tate C.G., Hasse J., Baker C., Boorsma M., Magnani F., Vallis Y., Williams D.C. Comparison of seven different heterologous protein expression systems for the production of the serotonin transporter. Biochim. Biophys. Acta 2003, 1610:141-153.
35. Tamura D., Mitamura K., Yamazaki M., Fujino M., Nirasawa M., Kimura K., Kiso M., Shimizu H., Kawakami C., Hiroi S., Takahashi K., Hata M., Minagawa H., Kimura Y., Kaneda S., Sugita S., Horimoto T., Sugaya N., Kawaoka Y. Oseltamivir-resistant influenza a viruses circulating in Japan. J. Clin. Microbiol. 2009, 47:1424-1427.
36. Tanimoto T., Matsuura Y., N.Y., Fuke I., Ishikawa T., Yamanishi K., Tamura S. Expression of influenza neuraminidase in CHO-K1 cells. International Congress Series, vol. 1263 2004, 568-572.
37. von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Van Phan T., Smythe M.L., White H.F., Oliver S.W., et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363:418-423.
38. Wanitchang A., Wongwisarnsri S., Yongkiettrakul S., Jongkaewwattana A. Extraction of catalytically active neuraminidase of H5N1 influenza virus using thrombin proteolytic cleavage. J. Virol. Methods 2010, 163:137-143.
39. Wu J.C., Peet G.W., Coutts S.J., Eckner R.J., Griffin J.A., Farina P.R. Non-sialate inhibitor of influenza A/WSN/33 neuraminidase. Biochemistry 1995, 34:7154-7160.
40. Yen H.L., Ilyushina N.A., Salomon R., Hoffmann E., Webster R.G., Govorkova E.A. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J. Virol. 2007, 81:12418-12426.
41. Yongkiettrakul S., Boonyapakron K., Jongkaewwattana A., Wanitchang A., Leartsakulpanich U., Chitnumsub P., Eurwilaichitr L., Yuthavong Y. Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. J. Virol. Methods 2009, 156:44-51.